Ralf Gold

Error processing in Huntington's disease.

Re-expression of a developmentally restricted potassium channel in autoimmune demyelination: Kv1.4 is implicated in oligodendroglial proliferation.

Current and future standards in treatment of myasthenia gravis.

Rapid regulatory T-cell response prevents cytokine storm in CD28 superagonist treated mice.

Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system.

The impact of fingolimod (FTY720) in neuroimmunologic diseases: mechanisms beyond immunomodulation.

Translational research in neurology and neuroscience 2010: multiple sclerosis.

Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?

Anti-inflammatory effects of the anticonvulsant drug levetiracetam on electrophysiological properties of astroglia are mediated via TGFβ1 regulation.

Depression in patients with Huntington disease correlates with alterations of the brain stem raphe depicted by transcranial sonography.

Evolving expectations around early management of multiple sclerosis.

Discordant findings in color-coded duplex-sonography and magnetic resonance angiography in symptomatic internal carotid artery stenosis: implications for diagnostic work-up and early intervention.

Efficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington's disease.

Functional energetics of CD4+-cellular immunity in monoclonal antibody-associated progressive multifocal leukoencephalopathy in autoimmune disorders.

Standard and escalating treatment of chronic inflammatory demyelinating polyradiculoneuropathy.

Central nervous system rather than immune cell-derived BDNF mediates axonal protective effects early in autoimmune demyelination.

Constitutive activity of NF-kappa B in myeloid cells drives pathogenicity of monocytes and macrophages during autoimmune neuroinflammation.

Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany.

Potassium channel KIR4.1 as an immune target in multiple sclerosis.

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis.

Multiple sclerosis and pregnancy: experience from a nationwide database in Germany.

Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters.

Ventricular tachycardia during basilar-type migraine attack.

Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients.

Improving the default data analysis workflow for large autoimmune biomarker discovery studies with ProtoArrays.

Sex and gender issues in multiple sclerosis.

Detection of patient subgroups with differential expression in omics data: a comprehensive comparison of univariate measures.

Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathy.

Highly immunoreactive IgG antibodies directed against a set of twenty human proteins in the sera of patients with amyotrophic lateral sclerosis identified by protein array.

Efficacy and side effects of natalizumab therapy in patients with multiple sclerosis.

Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study.

Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study.

Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study.

High noon back pain- severe pseudoradicular pain as a lead symptom of superficial siderosis: a case report.

Rituximab postprogressive multifocal leukoencephalopathy: a Feasible therapeutic option in selected cases.

Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease.

MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4.

Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials.

Glial cells express nuclear nrf2 after fumarate treatment for multiple sclerosis and psoriasis.

Combinations of susceptibility genes are associated with higher risk for multiple sclerosis and imply disease course specificity.

Cortical and Subcortical Grey and White Matter Atrophy in Myotonic Dystrophies Type 1 and 2 Is Associated with Cognitive Impairment, Depression and Daytime Sleepiness.

Dagibatran Etexilate: Is There Any Need for Coagulation Monitoring After Initiation?

Low dose fumaric acid esters are effective in a mouse model of spontaneous chronic encephalomyelitis.

Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses.

PML risk stratification using anti-JCV antibody index and L-selectin.

Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine.

Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array.

Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-related Hospitalizations: Integrated Analysis of the Delayed-release Dimethyl Fumarate Phase III Studies.

Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment.

Hypoechogenicity of brainstem raphe nuclei is associated with increased attack frequency in episodic migraine.

Glatiramer acetate during early pregnancy: A prospective cohort study.

Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry.

Transorbital sonography in CIDP patients: No evidence for optic nerve hypertrophy.

Relevance of endoglin, IL-1α, IL-1β and anti-ovarian antibodies in females with multiple sclerosis.

Basal ganglia alterations appearing in transcranial sonography prior to MRI in a patient with Creutzfeld-Jacob Disease.

Positive Effect on Multiple Sclerosis With Treatment of Metabolic Syndrome.

High salt drives Th17 responses in experimental autoimmune encephalomyelitis without impacting myeloid dendritic cells.

Plasmapheresis and immunoadsorption in patients with steroid refractory multiple sclerosis relapses.

Tocilizumab, MS, and NMOSD.

Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registry.

Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study.

Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation.

Pregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program.

Listeria rhombencephalitis mimicking a demyelinating event in an immunocompetent young patient.

Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study.

Introduction: Do we need multi-stakeholder colloquia in MS?

The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?

The payer's perspective: What is the burden of MS and how should the patient's perspective be integrated in health technology assessment conducted for taking decisions on access to care and treatment?

Conclusions: Calls to action for improving the life of MS patients and their families.

Charles Bonnet syndrome successfully treated with levetiracetam.

"Punched nerve syndrome" as contributing factor for "Saturday night palsy".

Expression of brain-derived neurotrophic factor in astrocytes - Beneficial effects of glatiramer acetate in the R6/2 and YAC128 mouse models of Huntington's disease.

Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy.

The immunomodulatory effect of laquinimod in CNS autoimmunity is mediated by the aryl hydrocarbon receptor.

Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies.

Active immunotherapy may delay disability in progressive MS.

Amphiphysin-positive paraneoplastic myelitis and stiff-person syndrome.

Immunotherapy Improves Cognitive Function in Secondary Progressive Multiple Sclerosis.

Role of the receptor Mas in macrophage-mediated inflammation in vivo.

Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy.

Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies.

Progressive spinal cord atrophy in manifest and premanifest Huntington's disease.

Trigemino-autonomic headache and Horner syndrome as a first sign of granulomatous hypophysitis.

Teaching Neuro: Sonographic detection of intraneural perineurioma in therapy-refractory carpal tunnel syndrome.

Teriflunomide and monomethylfumarate target HIV-induced neuroinflammation and neurotoxicity.

Treatment of multiple sclerosis during pregnancy - safety considerations.

Two years' long-term follow up in chronic inflammatory demyelinating polyradiculoneuropathy: efficacy of intravenous immunoglobulin treatment.

Coronal Transcranial Sonography and M-Mode Tremor Frequency Determination in Parkinson's Disease and Essential Tremor.

Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).

Management of patients with malignancies and secondary immunodeficiencies treated with immunoglobulins in clinical practice: Long-term data of the SIGNS study.

Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis.

Relevance of early cervical cord volume loss in the disease evolution of clinically isolated syndrome and early multiple sclerosis: a 2-year follow-up study.

Testosterone Differentially Affects T Cells and Neurons in Murine and Human Models of Neuroinflammation and Neurodegeneration.

Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS.

Laquinimod treatment in the R6/2 mouse model.

Unilateral right prosopometamorphopsia with positive "half-face-covering-test" after small occipitotemporal stroke.

Dimethyl fumarate for patients with neuromyelitis optica spectrum disorder.

Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM.

Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?

Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation.

Insight into Metabolic H-MRS Changes in Natalizumab Induced Progressive Multifocal Leukoencephalopathy Brain Lesions.

Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience.

Patient-reported outcomes in relapsing forms of MS: Real-world, global treatment experience with teriflunomide from the Teri-PRO study.

Consistent efficacy of daclizumab beta across patient demographic and disease activity subgroups in patients with relapsing-remitting multiple sclerosis.

Lewis Rat Model of Experimental Autoimmune Encephalomyelitis.

Dietary fatty acids and susceptibility to multiple sclerosis.

Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's disease.

Role of Nuclear Factor (Erythroid-Derived 2)-Like 2 Signaling for Effects of Fumaric Acid Esters on Dendritic Cells.

Clinical commentary on 'Severe hypertriglyceridemia associated with teriflunomide in a patient with multiple sclerosis'.

Oral Therapies for Multiple Sclerosis.

Treatment choices and neuropsychological symptoms of a large cohort of early MS.

Corrigendum to 'Effects of Delayed-release Dimethyl Fumarate (DMF) on Health-related Quality of Life in Patients With Relapsing-remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies: [Clinical Therapeutics 36 (2014) 1958-1971].

Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis.

Mechanical thrombectomy in a young stroke patient with Duchenne muscular dystrophy.

High-resolution nerve ultrasound and magnetic resonance neurography as complementary neuroimaging tools for chronic inflammatory demyelinating polyneuropathy.

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.

Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010.

Capsaicin-enriched diet ameliorates autoimmune neuritis in rats.

Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study.

Correction to: Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010.

Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model.

DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis.

The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis.

Detection of JC virus archetype in cerebrospinal fluid in a MS patient with dimethylfumarate treatment without lymphopenia or signs of PML.

Breakthrough treatment with bortezomib for a patient with anti-NMDAR encephalitis.

Ovarian Reserve in Women With Neuromyelitis Optica Spectrum Disorder.

Flaccid paralysis in neuromyelitis optica: An atypical presentation with possible involvement of the peripheral nervous system.

Monitoring of structural changes in the course of acute compressive radial neuropathies by means of high resolution nerve ultrasound.

Brainstem Raphe Alterations in TCS: A Biomarker for Depression and Apathy in Parkinson's Disease Patients.

Prospective Study of the Clinical, Electrophysiologic, and Sonographic Characteristics of Oxaliplatin-Induced Neuropathy.

Patient-reported outcomes in patients with relapsing forms of MS switching to teriflunomide from other disease-modifying therapies: Results from the global Phase 4 Teri-PRO study in routine clinical practice.

Landscape of pain in Parkinson's disease: impact of gender differences.

Peripheral CD19 B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders.

Successful therapy with rituximab in three patients with probable neurosarcoidosis.

Clinical, Sonographic, and Electrophysiologic Longitudinal Features of Chronic Inflammatory Demyelinating Polyneuropathy.

Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS).

Emerging Immunotherapies for Parkinson Disease.

Treatment of an acute motor and sensory axonal neuropathy with propionate in a 33-year-old male.

Nerve echogenicity and intranerve CSA variability in high-resolution nerve ultrasound (HRUS) in chronic inflammatory demyelinating polyneuropathy (CIDP).

Impairment of Motor Function Correlates with Neurometabolite and Brain Iron Alterations in Parkinson's Disease.

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson's Disease.

Dynamics of Parkinson's Disease Multimodal Complex Treatment in Germany from 2010⁻2016: Patient Characteristics, Access to Treatment, and Formation of Regional Centers.

Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution.

Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients.

Intrathecal triamcinolone acetonide exerts anti-inflammatory effects on Lewis rat experimental autoimmune neuritis and direct anti-oxidative effects on Schwann cells.

Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis.

Author Correction: Laquinimod treatment in the R6/2 mouse model.

A protein quality control pathway regulated by linear ubiquitination.

Author Correction: Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution.

Teriflunomide real-world evidence: Global differences in the phase 4 Teri-PRO study.

Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis.

Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis.

Three cases of non-carryover fingolimod-PML: Is the risk in Japan increased?

Antineuroinflammatory drugs in HIV-associated neurocognitive disorders as potential therapy.

Dynamics of device-based treatments for Parkinson's disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa-carbidopa intestinal gel, and deep brain stimulation.

Neuroimaging markers of clinical progression in chronic inflammatory demyelinating polyradiculoneuropathy.

Heterogeneous GBS course requires standardized guidelines.

Extensive immune reconstitution inflammatory syndrome in Fingolimod-associated PML: a case report with 7 Tesla MRI data.

Progressive multiple sclerosis: from pathophysiology to therapeutic strategies.

Brainstem Encephalitis With Low-Titer Acetylcholine Receptor Antibodies Mimicking Myasthenia Gravis.

Hereditary defect of cobalamin metabolism with adolescence onset resembling multiple sclerosis: 41-year follow up in two cases.

Induction of Regulatory Properties in the Intestinal Immune System by Dimethyl Fumarate in Lewis Rat Experimental Autoimmune Neuritis.

Elevated levels of miR-181c and miR-633 in the CSF of patients with MS: A validation study.

Progressive multiple sclerosis: latest therapeutic developments and future directions.

Effects of IVIg treatment on autoantibody testing in neurological patients: marked reduction in sensitivity but reliable specificity.

Temporal Dynamics of Diffusion Metrics in Early Multiple Sclerosis and Clinically Isolated Syndrome: A 2-Year Follow-Up Tract-Based Spatial Statistics Study.

Smad7 in intestinal CD4 T cells determines autoimmunity in a spontaneous model of multiple sclerosis.

Lentiform Nucleus Hyperechogenicity in Parkinsonian Syndromes: A Systematic Review and Meta-Analysis with Consideration of Molecular Pathology.

Novel variants in a patient with late-onset hyperprolinemia type II: diagnostic key for status epilepticus and lactic acidosis.

Developmental Venous Anomalies are More Common in Patients with Multiple Sclerosis and Clinically Isolated Syndrome : Coincidence or Relevant?

Dimethyl fumarate vs fingolimod following different pretreatments: A retrospective study.

DeepWAS: Multivariate genotype-phenotype associations by directly integrating regulatory information using deep learning.

Endocarditis following ocrelizumab in relapsing-remitting MS.

Binding patterns and functional properties of human antibodies to AQP4 and MOG on murine optic nerve and retina.

Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism.

Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort study.

Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder.

Is ε4 associated with cognitive performance in early MS?

Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis.

Immunomodulatory and anti-oxidative effect of the direct TRPV1 receptor agonist capsaicin on Schwann cells.

Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years' follow-up of DEFINE, CONFIRM, and ENDORSE.

Longitudinal study on nerve ultrasound and corneal confocal microscopy in NF155 paranodopathy.

Safety of potential breast milk exposure to IFN-β or glatiramer acetate: One-year infant outcomes.

Early immunotherapy is highly effective in IgG1/IgG4 positive IgLON5 disease.

Long-term safety and efficacy of daclizumab beta in relapsing-remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study.

Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study.

Propionic Acid and Fasudil as Treatment Against Rotenone Toxicity in an In Vitro Model of Parkinson's Disease.

Reader Response: Comparison of the Response to Rituximab between Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibody Diseases.

Cladribine transfer into human milk: A case report.

High-Resolution Nerve Ultrasound to Assess Nerve Echogenicity, Fascicular Count, and Cross-Sectional Area Using Semiautomated Analysis.

Parkinson's Disease Multimodal Complex Treatment (PD-MCT): Analysis of Therapeutic Effects and Predictors for Improvement.

A Multiplex Assay for the Stratification of Patients with Primary Central Nervous System Lymphoma Using Targeted Mass Spectrometry.

Genetic determinants of the humoral immune response in MS.

Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017.

Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient.

Multiple sclerosis and nutrition: back to the future?

Correlates of polyneuropathy in Parkinson's disease.

Delayed Diagnosis of Anti-Hu Antibodies in a Young Patient With Cerebellar Atrophy.

Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis.

Course of neuropsychological impairment during natalizumab-associated progressive multifocal leukoencephalopathy.

Serum neurofilament light chain as outcome marker for intensive care unit patients.

Chitinase 3-like 1 and neurofilament light chain in CSF and CNS atrophy in MS.

The role of the gut microbiota and microbial metabolites in neuroinflammation.

Dimethyl fumarate transfer into human milk.

Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis.

High-dose biotin in multiple sclerosis: the end of the road.

New Approaches to Critical Illness Polyneuromyopathy: High-Resolution Neuromuscular Ultrasound Characteristics and Cytokine Profiling.

TDP-43 as structure-based biomarker in amyotrophic lateral sclerosis.

General principles and escalation options of immunotherapy in autoantibody-associated disorders of the CNS.

Severe pneumonia with formation of a pulmonary cavity associated with long-term rituximab therapy in multiple sclerosis.

Comprehensive approaches for diagnosis, monitoring and treatment of chronic inflammatory demyelinating polyneuropathy.

Siponimod and Cognition in Secondary Progressive Multiple Sclerosis: EXPAND Secondary Analyses.

Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.

Increased muscle echointensity correlates with clinical disability and muscle strength in chronic inflammatory demyelinating polyneuropathy.

Pain, depression, and quality of life in adults with MOG-antibody-associated disease.

Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses.

Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS.

Cross-sectional area reference values for peripheral nerve ultrasound in adults: a systematic review and meta-analysis-Part I: Upper extremity nerves.

[Disease-modifying treatment of secondary progressive multiple sclerosis].

Treatment response to cyclophosphamide, rituximab, and bortezomib in chronic immune-mediated sensorimotor neuropathies: a retrospective cohort study.

Microstructural White Matter Alterations in Cognitively Impaired Patients at Early Stages of Multiple Sclerosis.

Cross-sectional area reference values for peripheral nerve ultrasound in adults: A systematic review and meta-analysis-Part II: Lower extremity nerves.

Improved gastrointestinal profile with diroximel fumarate is associated with a positive impact on quality of life compared with dimethyl fumarate: results from the randomized, double-blind, phase III EVOLVE-MS-2 study.

Evaluation of the EFNS/PNS diagnostic criteria in a cohort of CIDP patients.

Cross-sectional area reference values for peripheral nerve ultrasound in adults: A systematic review and meta-analysis-Part III: Cervical nerve roots and vagal nerve.

Analysis of nationwide multimodal complex treatment and drug pump therapy in Parkinson's disease in times of COVID-19 pandemic in Germany.

A Propagated Skeleton Approach to High Throughput Screening of Neurite Outgrowth for In Vitro Parkinson's Disease Modelling.

Clinical Profiles and Mortality of COVID-19 Inpatients with Parkinson's Disease in Germany.

Clozapine Regulates Microglia and Is Effective in Chronic Experimental Autoimmune Encephalomyelitis.

Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?

Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody-Seropositive Patients.

Usefulness of Computed Tomographic Perfusion Imaging for Appropriate Diagnosis of Acute Cerebral Vessel Occlusion in Case of Anatomic Variations of the Circle of Willis.

Propionic Acid Rescues High-Fat Diet Enhanced Immunopathology in Autoimmunity Effects on Th17 Responses.

CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient.

An algorithm using clinical data to predict the optimal individual glucocorticoid dosage to treat multiple sclerosis relapses.

The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from Germany.

[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)].

Corneal inflammatory cell infiltration predicts disease activity in chronic inflammatory demyelinating polyneuropathy.

Multiple sclerosis therapy consensus group (MSTCG): answers to the discussion questions.

Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome in seven patients with sarcoidosis: a critical discussion of treatment and prognosis.

Multiple sclerosis is not associated with an increased risk for severe COVID-19: a nationwide retrospective cross-sectional study from Germany.

COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis.

Short- and long-term outcome of patients with spontaneous echo contrast or thrombus in the left atrial appendage in the era of the direct acting anticoagulants.

Long-term safety and efficacy of dimethyl fumarate for up to 13 years in patients with relapsing-remitting multiple sclerosis: Final ENDORSE study results.

Maintenance therapy with subcutaneous immunoglobulin in a patient with immune-mediated neuropathic postural tachycardia syndrome.

Report of a fulminant anti-pan-neurofascin-associated neuropathy responsive to rituximab and bortezomib.

Hospital Admissions for Neurodegenerative Diseases during the First Wave of the COVID-19 Pandemic: A Nationwide Cross-Sectional Study from Germany.

Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism.